Effective postoperative analgesia provides an adequate comfort level along with acceptable side effects and produces early ambulation after surgery. The multi-modal analgesic regimen includes non-opioid analgesics such as local anesthetic to provide better postoperative pain relief and reduce side effects of opioids (
8). An optimal analgesic technique suppresses all the noxious stimuli involving parietal and visceral components from a surgical injury that engages peripheral and central sensitization from the primary afferent nociceptors and spinal dorsal horn neurons. Epidural analgesia is a commonly practiced regional neuraxial analgesia technique for abdominal surgery that covers both parietal and visceral components (
9). Epidural continuous approach techniques are associated with better pain relief compared to single injection nerve blocks. However, despite a reliable pain relief, it has several side effects such as paresthesia, hypotension, urinary disturbance, and complications such as inadvertent intra-thecal migration of the epidural catheter or epidural hematoma (
10). With an increase in the number of living kidney donations, it is important to optimize comfort and reliable but safe postoperative analgesia for the donor.
The ultrasound-guided TAP block has increasingly performed with lower complications as an interfascial plane block for abdominal surgery analgesia (
11). Our study demonstrated that the effects of three-quadrant TAP block using 0.25% bupivacaine with additional dexamethasone 8 mg and continuous epidural block using 0.125% bupivacaine were not significantly different in postoperative morphine consumption and pain scale 24 hours after transperitoneal laparoscopic donor nephrectomy. A study on patients undergoing hand-assisted laparoscopic nephrectomy showed that TAP block reduced pain scores and decreased total morphine consumption in the first 24 hours (
1). However, a meta-analysis showed that TAP block as part of multimodal analgesic regimen was superior to a placebo block or IV analgesics alone in reducing analgesic consumption and pain level only during 2 - 6 hours after laparoscopic abdominal surgery (
6) We chose the bilateral posterior and unilateral subcostal approach using 0.25% bupivacaine to provide adequate analgesia for the lower quadrant and the upper-half quadrant of the abdomen. The ultrasound-guided posterior TAP block produced a longer analgesia with higher patient satisfaction and lower mean values of pain score after cesarean section compared to the lateral TAP block (
11). The local anesthetic in the posterior approach provided somatic pain relief by blocking the lateral cutaneous branches of thoracolumbar nerve before branching and spreading regionally in the neurofascial TAP. It can reach into the paravertebral space to block the thoracolumbar sympathetic system from T7 to L1 (
2). We used a combination of bilateral posterior and unilateral subcostal approach TAP block with additional dexamethasone 8 mg in each injection to prolong the duration of analgesia. Additional glucocorticoid dexamethasone as a new adjunct to local anesthetics can be utilized to improve the duration of regional analgesia. Recent studies have shown that ultrasound-guided bilateral TAP block at the end of the cesarean section using 40 mL ropivacaine 0.2% and dexamethasone 8 mg prolonged the duration of TAP block and in patients undergoing open abdominal hysterectomy, the additional dexamethasone 8 mg to 0.25% bupivacaine improved the quality and duration of bilateral TAP block (
7). The mechanism involved in the prolongation of analgesia was suggested to be the systemic effect of dexamethasone on the inhibition of nociceptive C-fibres, as well as the anti-inflammatory effects. A meta-analysis by Choi et al. showed that the use of perineural dexamethasone significantly prolonged the duration of analgesia approximately by 6 hours compared to the use of IV dexamethasone. A recent meta-analysis by Hussein et al. showed that irrespective of dose, the use of perineural dexamethasone does not appear to provide a significant incremental benefit to the pain score, duration of analgesia or motor blockade, and cumulative opioid consumption when compared to the use of IV dexamethasone at a 24-hour follow-up (
12).
Our study showed blood glucose after the surgery was non-significantly higher in the TAP block group due to additional dexamethasone; however, no symptom or complication due to hyperglycemia was observed. Our result was similar to the findings of a previous study that showed a non-significant difference in blood glucose level between additional dexamethasone and placebo groups (
13). This suggests adding dexamethasone cautiously in diabetic patients although this hypothesis must be confirmed by further research in this patient population. Williams et al. evaluated the toxicity of perineural adjuvants to ropivacaine in an animal model and proved the administration of supratherapeutic doses of dexamethasone for two hours did not appear to cause neuronal cell death (
12). Future studies should focus on evaluating the dose-dependent analgesic effects of perineural or interfascial dexamethasone addition.
The total dose of bupivacaine used was 150 mg in the TAP block and less than 180 mg in the continuous epidural group. The efficacy of bupivacaine with different concentrations has been studied in peripheral nerve blocks. Research findings suggested that patients receiving 0.25% bupivacaine had lower pain with higher satisfaction while the duration of anesthesia showed no difference compared to the group receiving 0.5% bupivacaine (
14). We chose 0.25% bupivacaine for the TAP block since those concentrations produce good analgesia and prevent local anesthetic toxicity. The concentration of 0.125% bupivacaine for the continuous epidural block was proven effective for postoperative pain management after an abdominal surgery with a lower incidence of leg weakness and paresthesia (
15). In our study, the TAP block group had a lower NRS during movement, especially at 12 hours after surgery (P = 0.004). The epidural was attached to the T12 - L1 level and the administration of 3 mL bupivacaine 0.125% as the initial bolus followed by 6 mL per hour might only reach the T10 - L1 level. The main target was postoperative pain from the Pfannenstiel incision, requiring analgesia at the T11 - L1 level that could be resolved by bilateral TAP blocks and continuous epidurals in this study. In the epidural group, trocar incision in the upper abdomen may not be blocked, which could cause pain, especially when the patient was moving. However, if the epidural block was performed at a higher level, it would be necessary to use a higher dose of bupivacaine with a larger volume to be able to block approximately from T7 - T8 to L1.
TAP block and opioids can control the parietal pain, whereas steroid controls the visceral pain (
10). Our primary outcome was opioid consumption during the first 24 hours after surgery. The PCA device was used to administer morphine under patient control without a continuous basal infusion in our study. Intravenous PCA enhances morphine delivery when the parenteral route is needed for postoperative systemic analgesia based on patients demand who self-administered the drug only when they felt pain (
8,
16). We avoid the basal infusion of morphine as recommended since our subjects were all opioid-naive patients (
17). The morphine consumption at all measurement times and the cumulative consumption in the first 24 hours after surgery were not significantly different between the TAP group and the continuous epidural group. This result was similar to another study finding that showed ultrasound-guided TAP block following hysterectomy did not significantly decrease the postoperative fentanyl consumption and pain score compared to standard treatment (
18). The first-time mobilization after surgery was not significantly different between the groups. Although the surgeon removed the urinary catheter as soon as the patient no longer needed it, the duration of urinary catheterization was significantly longer in the epidural group as a complication that prevented patients from early returning to the normal function.
This study faced several limitations. The sensory testing to evaluate the block level was not recorded. This study did not assess nausea, vomiting, and epigastric pain because the antiemetic was given immediately to prevent those complications owing to the laparoscopy procedure. However, relieving those gastrointestinal discomforts could reduce bias while assessing the postoperative pain in this study. This is an open-label study in which the epidural catheter insertion was done before surgery with a small test dose bolus; therefore, its’ effects might be subsided at the end of the surgery. The epidural block started with a bolus followed by a continuous rate infusion after surgery, which was similar to the TAP block but there was still a bias. We excluded patients with BMI > 30; thus, the results of this study cannot be generalized to that population. For the future study, it is better to compare the TAP block with/without dexamethasone and the epidural block.
4.1. Conclusion
The present study showed the analgesic effect of three-quadrant TAP block with additional dexamethasone was not significantly different from the effect of continuous epidural analgesia for the first 24 hours after surgery. Therefore, it can be an alternative approach as part of multimodal analgesia following transperitoneal laparoscopic donor nephrectomy and other lower abdominal surgeries with Pfannenstiel incision.